HELP     Sign In
Search

Relevance to Autism

This gene has been associated with syndromic autism, where a subpopulation of individuals with a given syndrome develop autism. In particular, rare mutations of the CHD7 gene have been identified with CHARGE syndrome (Vissers et al., 2004), and a rare mutation in the CHD7 gene has been identified in an individual with ASD (ORoak et al., 2012).

Molecular Function

This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.
CHARGE syndrome
ASD
Support
Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.
Support
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.
ASD
Support
ASD
Support
An Intronic Variant of CHD7 Identified in Autism Patients Interferes with Neuronal Differentiation and Development
ASD
Support
The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.
Multiple congenital anomalies
Support
Integrating de novo and inherited variants in 42
ASD
Support
Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8.
Support
CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.
Support
ASD
DD, ID, epilepsy/seizures
Support
Should autism spectrum disorder be considered part of CHARGE syndrome? A cross-sectional study of 46 patients
CHARGE syndrome
Support
De novo genic mutations among a Chinese autism spectrum disorder cohort.
ASD
Support
Whole-exome sequencing identified five novel de novo variants in patients with unexplained intellectual disability
DD, ID
Support
Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder.
ASD
Support
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
ASD
Support
Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability
ID
Support
Clinical Targeted Panel Sequencing Analysis in Clinical Evaluation of Children with Autism Spectrum Disorder in China
ASD
Support
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands.
Congenital heart disease (CHD)
Neurodevelopmental disorders (NDD)
Support
ASD
Support
Autism-associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans.
ASD
Support
Large-scale discovery of novel genetic causes of developmental disorders.
ID
Support
Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy
Epilepsy/seizures
Support
Genomic diagnosis for children with intellectual disability and/or developmental delay.
ID
Support
ADHD, DD, ID
Support
Comprehensive Analysis of Rare Variants of 101 Autism-Linked Genes in a Hungarian Cohort of Autism Spectrum Disorder Patients.
ASD
CHARGE syndrome
Support
Performance comparison of bench-top next generation sequencers using microdroplet PCR-based enrichment for targeted sequencing in patients with aut...
ASD
ID, epilepsy
Support
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability
ASD, ADHD, ID
Support
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
ASD
Support
CHARGE syndrome
Support
Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.
ASD
Support
Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing.
ASD
Support
ID
Support
CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum
CHARGE syndrome
Support
Clinical exome sequencing: results from 2819 samples reflecting 1000 families.
CHARGE syndrome
ASD, ID
Recent Recommendation
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies.
Congenital heart disease (CHD)
DD, learning disabilities
Recent Recommendation
Low load for disruptive mutations in autism genes and their biased transmission.
ASD
Recent Recommendation
Craniosynostosis
Recent Recommendation
CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.
Recent Recommendation
The CHD8/CHD7/Kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects
Insomnia
Recent Recommendation
The chromatin remodeler CHD7 regulates adult neurogenesis via activation of SoxC transcription factors.
Recent Recommendation
Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme.
Recent Recommendation
Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders.
Recent Recommendation
The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.
Recent Recommendation
Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN280R001 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN280R002 
 translocation 
  
  
  
  
  
 GEN280R003 
 stop_gained 
 c.469C>T 
 p.Arg157Ter 
  
  
  
 GEN280R004 
 stop_gained 
 c.1078G>T 
 p.Gly360Ter 
  
  
  
 GEN280R005 
 stop_gained 
 c.1714C>T 
 p.Gln572Ter 
 De novo 
  
  
 GEN280R006 
 missense_variant 
 c.3082A>G 
 p.Ile1028Val 
 De novo 
  
  
 GEN280R007 
 missense_variant 
 c.3770T>G 
 p.Leu1257Arg 
 De novo 
  
  
 GEN280R008 
 stop_gained 
 c.5418C>G 
 p.Tyr1806Ter 
 De novo 
  
  
 GEN280R009 
 stop_gained 
 c.6051T>A 
 p.Cys2017Ter 
  
  
  
 GEN280R010 
 stop_gained 
 c.6070C>T 
 p.Arg2024Ter 
  
  
  
 GEN280R011 
 stop_gained 
 c.7824T>A 
 p.Tyr2608Ter 
 De novo 
  
  
 GEN280R012 
 splice_site_variant 
 G>A 
 p.? 
 De novo 
  
  
 GEN280R013 
 missense_variant 
 c.2986G>A 
 p.Gly996Ser 
 De novo 
  
 Simplex 
 GEN280R014 
 frameshift_variant 
 c.2245del 
 p.Leu749Ter 
 Familial 
 Maternal 
 Simplex 
 GEN280R015 
 frameshift_variant 
 c.8941_8942insA 
 p.Leu2981HisfsTer5 
 Familial 
 Paternal 
 Simplex 
 GEN280R016 
 missense_variant 
 c.3566G>A 
 p.Arg1189His 
 Familial 
 Paternal 
 Simplex 
 GEN280R017 
 missense_variant 
 c.7880G>A 
 p.Arg2627Gln 
 Unknown 
  
 Unknown 
 GEN280R018 
 missense_variant 
 c.7652C>A 
 p.Thr2551Asn 
 Unknown 
  
 Unknown 
 GEN280R019 
 copy_number_loss 
  
  
 De novo 
  
 Simplex 
 GEN280R020 
 missense_variant 
 c.2657G>A 
 p.Arg886Gln 
 De novo 
  
 Simplex 
 GEN280R021 
 stop_gained 
 c.1717-20232C>T 
  
 De novo 
  
  
 GEN280R022 
 stop_gained 
 c.5181C>G 
 p.Tyr1727Ter 
 De novo 
  
  
 GEN280R023 
 missense_variant 
 c.4516G>A 
 p.Gly1506Ser 
 Familial 
 Maternal 
  
 GEN280R024 
 missense_variant 
 c.4516G>A 
 p.Gly1506Ser 
 Familial 
 Paternal 
  
 GEN280R025 
 stop_gained 
 c.2959C>T 
 p.Arg987Ter 
 De novo 
  
  
 GEN280R026 
 translocation 
  
  
 De novo 
  
  
 GEN280R027 
 frameshift_variant 
 ACCAGTGTCTG>A 
  
 De novo 
  
 Simplex 
 GEN280R028 
 missense_variant 
 c.6955C>T 
 p.Arg2319Cys 
 De novo 
  
  
 GEN280R029 
 stop_gained 
 c.1717-5658C>T 
  
 De novo 
  
  
 GEN280R030 
 stop_gained 
 c.1717-11683C>T 
  
 De novo 
  
  
 GEN280R031 
 missense_variant 
 c.7880G>A 
 p.Arg2627Gln 
 De novo 
  
 Simplex 
 GEN280R032 
 missense_variant 
 c.7193G>A 
 p.Arg2398His 
 Familial 
 Paternal 
 Simplex 
 GEN280R033 
 missense_variant 
 c.7502C>A 
 p.Ser2501Tyr 
 Unknown 
 Not maternal 
 Simplex 
 GEN280R034 
 frameshift_variant 
 c.1717-20205del 
  
 De novo 
  
  
 GEN280R035 
 synonymous_variant 
 c.1263A>G 
 p.Pro421= 
 De novo 
  
  
 GEN280R036 
 intron_variant 
 c.4851-31C>T 
  
 Familial 
 Paternal 
 Simplex 
 GEN280R037 
 intron_variant 
 c.4851-31C>T 
  
 Familial 
 Paternal 
 Simplex 
 GEN280R038 
 intron_variant 
 c.4851-31C>T 
  
 Familial 
 Paternal 
 Simplex 
 GEN280R039 
 intron_variant 
 c.4851-31C>T 
  
 Familial 
 Paternal 
 Simplex 
 GEN280R040 
 intron_variant 
 c.1717-17396C>T 
  
 Familial 
 Paternal 
 Simplex 
 GEN280R041 
 intron_variant 
 c.4851-31C>T 
  
 Familial 
 Maternal 
 Simplex 
 GEN280R042 
 frameshift_variant 
 c.4493_4506del 
 p.Ile1498ArgfsTer9 
 Unknown 
  
  
 GEN280R043 
 stop_gained 
 c.2643T>A 
 p.Tyr881Ter 
 Unknown 
  
  
 GEN280R044 
 stop_gained 
 c.5181C>G 
 p.Tyr1727Ter 
 Unknown 
  
  
 GEN280R045 
 stop_gained 
 c.844C>T 
 p.Gln282Ter 
 De novo 
  
  
 GEN280R046 
 missense_variant 
 c.304C>T 
 p.His102Tyr 
 Familial 
 Paternal 
  
 GEN280R047 
 missense_variant 
 c.7013A>T 
 p.Gln2338Leu 
 De novo 
  
 Simplex 
 GEN280R048 
 stop_gained 
 c.7252C>T 
 p.Arg2418Ter 
 De novo 
  
  
 GEN280R049 
 synonymous_variant 
 c.1644G>A 
 p.Pro548%3D 
 De novo 
  
  
 GEN280R050 
 missense_variant 
 c.3640C>G 
 p.Gln1214Glu 
 De novo 
  
  
 GEN280R051 
 missense_variant 
 c.5050G>A 
 p.Gly1684Ser 
 De novo 
  
  
 GEN280R052 
 missense_variant 
 c.7708C>T 
 p.Pro2570Ser 
 De novo 
  
  
 GEN280R053 
 missense_variant 
 c.8326C>T 
 p.Pro2776Ser 
 De novo 
  
  
 GEN280R054 
 missense_variant 
 c.8692A>G 
 p.Met2898Val 
 De novo 
  
  
 GEN280R055 
 missense_variant 
 c.6307G>A 
 p.Gly2103Ser 
 De novo 
  
 Simplex 
 GEN280R056 
 missense_variant 
 c.2176G>T 
 p.Asp726Tyr 
 Familial 
  
 Multiplex 
 GEN280R057 
 frameshift_variant 
 c.2352dup 
 p.Asn785GlnfsTer12 
 Unknown 
 Not maternal 
  
 GEN280R058 
 missense_variant 
 c.2701G>A 
 p.Val901Met 
 Familial 
 Maternal 
  
 GEN280R059 
 missense_variant 
 c.5202C>A 
 p.His1734Gln 
 De novo 
  
  
 GEN280R060 
 missense_variant 
 c.6904G>A 
 p.Glu2302Lys 
 Unknown 
  
 Extended multiplex 
 GEN280R061 
 missense_variant 
 c.3973T>C 
 p.Tyr1325His 
 Unknown 
  
  
  et al.  
 GEN280R062 
 missense_variant 
 c.3973T>C 
 p.Tyr1325His 
 Unknown 
  
  
  et al.  
 GEN280R063 
 stop_gained 
 c.2839C>T 
 p.Arg947Ter 
 De novo 
  
  
  et al.  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
8
Duplication
 1
 
8
Duplication
 1
 
8
Deletion
 1
 
8
Duplication
 1
 
8
Deletion
 2
 

Model Summary

The deletion of Chd7 causes inner year problems in the mouse model and mutations in this gene have been found in some patients with the CHARGE syndrome.

References

Type
Title
Author, Year
Primary
Otitis media in a new mouse model for CHARGE syndrome with a deletion in the Chd7 gene.
Additional
The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.
Additional
CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum

M_CHD7_1_SP_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Mice designated as OME ( otitis media and eye defects) mice, as hearing deficits were observed in these mice in the Jackson Laboratory- these mice harbor a spontaneous mutation, transmitted in an autosomal dominant manner, located somewhere in the Chd7 gene- the exact location is not known. Exon 1 and 4 are spliced together leading to the deletion of exon 2 and 3.
Allele Type: NA
Strain of Origin:
Genetic Background: BALB/cByJ
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_CHD7_2_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of critical exons located between positions 8784907 and 8786002 (Chromosome 4 ) of the Chd7 gene using Nestin-cre, in neuronal, glial and other cell types in the central and peripheral nervous system
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL/6N
Genetic Background: C57BL/6N* C57BL/6J
ES Cell Line: JM8
Mutant ES Cell Line:
Model Source:

M_CHD7_3_CKO_HM_GRANULEN

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Conditional deletion of exon 3 of the Chd7 using Math1-cre, specifically from cerebellar granule cell lineage, starting around E14.5
Allele Type: Conditional loss-of-function
Strain of Origin: C57BL/6N
Genetic Background: C57BL/6N* C57BL/6J
ES Cell Line: JM8
Mutant ES Cell Line:
Model Source:

M_CHD7_4_CKO_HM_ATOH1

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Atoh1 (math1) enhancer driven cre transgenic line to conditionally trigger knockout of the chd7 gene selectively in the granule cell lineage at the time of specification in the rhombic lip15. chd7fl/fl mice were obtained from eucomm, and the neomycin selection cassette was removed by crossing with flp deleter mice. jq2-atoh1 promoter fragment was ligated to the bacteriophage p1 cre recombinase cdna and injected into mouse embryo pro-nuclei to generate two transgenic mouse lines that carried the atoh1-cre.
Allele Type: Conditional loss of function
Strain of Origin:
Genetic Background: not specified
ES Cell Line: not specified
Mutant ES Cell Line:
Model Source: 34588434; 23827709; 16145671; 11502254

M_CHD7_1_SP_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Swimming ability1
Decreased
Description: Poor swimming ability was observed in chd7 hets
Exp Paradigm: NA
 NA
 Unreported
Head bobbing1
Increased
Description: Chd7 heterozygous mutants showed increased head bobbling movements
Exp Paradigm: NA
 General observations
 Unreported
Circling1
Increased
Description: Chd7 heterozygous mutants showed increased circling
Exp Paradigm: NA
 General observations
 Unreported
Inner ear anatomy1
Increased
Description: Chd7 hets have middle and inner ear abnormalities- otitis media, as well has eye defects (keratoconjunctivitis sicca). increased effusion by inflammatory cells in the middle ear and eustachian canal, thickened epithelia, dilated periostem were observed . increase in goblet cells in the middle ear and eustachian canal. reduced ciliary density in the eustachian tube was also seen.
Exp Paradigm: Ear samples were decalcified and embedded in paraffin. sections were cut and stained with hematoxylin/eosin. the middle an dinner ears were assessed for pathological problems, like middle ear effusion, inflammatory cell infiltration, tissue debris and tissue proliferation, number of cilia.
 Histology
 3-11 weeks
Hearing1
Decreased
Description: The mean abr thresholds for chd7 hets in each age group were significantly higher than those of wild type mice at all frequencies tested. the dpoae tests show that the hets have amplitudes below zero at very frequency tested. tympanometry measurement showed lower compliance values in hets.
Exp Paradigm: A computer aided evoked potential system was used to measure mouse abr thresholds and dpoae amplitudes.
 Auditory brainstem response test
 3-17 weeks
Skeletal development: craniofacial1
Increased
Description: Craniofacial abnormalities are observed. larger skull height/ skull length , larger nose bone length/ skull length, greater eustachian tube angle was seen in the chd7 hets.
Exp Paradigm: NA
 Cranial measurements
 Unreported
Size/growth1
Decreased
Description: Chd7 hets are smaller in size and weight at weaning age
Exp Paradigm: NA
 General observations
 3-4 weeks
General characteristics1
 No change
 General observations
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Seizure, Social behavior

M_CHD7_2_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Cerebellar morphology1
Decreased
Description: Cerebellar size is disproportionately reduced with hypoplasia of the cerebellar lobules and vermis in chd7 cko mice (only two cko mice survived and were analyzed at p21)
Exp Paradigm: NA
 Histology
 P0, p14, p21
Cerebellar foliation1
Decreased
Description: Chd7 cko mice have smaller and irregular cerebellar folia, with vermis folia iv-v, and ix extended towards lateral hemispheres
Exp Paradigm: NA
 Histology
 P14, p21
Size/growth1
Decreased
Description: Chd7 cko mice are smaller than wt controls
Exp Paradigm: NA
 Body weight measurement
 P21
Mortality/lethality1
Increased
Description: Chd7 neural stem cell cko mice are born in mendelian ratios but have a low survival rate by p21
Exp Paradigm: NA
 General observations
 P0-p21
Targeted expression1
Decreased
Description: Chd7 mrna is not detectable by e12.5 in the brain and at birth there is complete lack of chd7 protein in the brain of mutant mice
Exp Paradigm: NA
 In situ hybridization (ish)
 E12.5, p0
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_CHD7_3_CKO_HM_GRANULEN

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Righting response1
Decreased
Description: Righting reflex is lowered in chd7 gcp specific knockout pups
Exp Paradigm: NA
 Righting reflex test
 P4
Negative geotaxis1
Decreased
Description: Chd7 gcp specific ko mice have impaired negative geotaxis
Exp Paradigm: NA
 Negative geotaxis test
 P8, p10
Motor coordination and balance1
Decreased
Description: Male chd7 gcp specific ko mice have reduced motor coordination and shorter latency to fall off on the rotarod compared to sex, age-matched wt controls
Exp Paradigm: NA
 Accelerating rotarod test
 P42-45
Cell proliferation: neural precursors: granule cell precursors1
Decreased
Description: Chd7 gcp specific ko leads to reduced proliferation of gcps in vermis lobules i-viii detected by brdu incorporation, authors note there was no change in brdu staining in the hemispheres
Exp Paradigm: NA
 Immunohistochemistry
 E18.5, p0, p1
Neuronal differentiation1
Decreased
Description: Impaired differentiation of purkinje cell progenitors and mislocalization are evident in the vermis and hemispheres by e18.5
Exp Paradigm: NA
 NA
 NA
Cerebellar morphology1
Decreased
Description: Chd7 granule cell precursor (gcp) specific knockouts had hypoplasia of all cerebellar lobules and hemispheres
Exp Paradigm: NA
 Histology
 P7, p21
Cerebellar foliation1
Decreased
Description: Chd7 gcp specific ko leads to delayed foliation and irregular or abnormal folia
Exp Paradigm: NA
 NA
 !.5, p2 ,p7, p10, p21
Neuronal number: purkinje cells1
Decreased
Description: Reduced number of purkinje cells are seen in lobules i-vii of cko animals, no change in density is observed
Exp Paradigm: NA
 NA
 NA
Apoptosis: brain cells1
Increased
Description: Increased apoptosis of gcps is observed in the hemispheres of chd7 gcp specific cko mice , authors note that increase in apoptosis did not reach significance in the vermis
Exp Paradigm: NA
 Expression of cleaved caspase-3 (cc3)
 P7
Chromatin modification: histone modification: open chromatin1
Decreased
Description: Dna accessibility, determined by dnase sequencing is found ot be reduced significantly in the gcps from chd7 gcp specific knockouts, specifically regulatory elements around the reln locus are reduced to some extent
Exp Paradigm: NA
 Dnase i hypersensitive sites sequencing (dnase-seq)
 P7
Targeted expression1
Decreased
Description: Chd7 knockout using math1-cre results in loss of chd7 protein from the cerebellar hemispheres starting e14.5, through postnatal stages, as expected
Exp Paradigm: In situ hybridization (ish)
 In situ hybridization (ish)
 P1, p7
Chromatin modification1
Abnormal
Description: Several regions of dna have increased as well as decreased dna accessibility, compared to wt, in gcps from p7 chd7 gcp specific knockout mice, determined using an assay that finds transposase-accessible chromatin with high-throughput sequencing
Exp Paradigm: NA
 Assay for transposase-accessible chromatin with high-throughput sequencing (atac-seq)
 P7
Targeted expression1
Decreased
Description: Chd7 knockout using math1-cre results in loss of chd7 protein from the cerebellar hemispheres starting e14.5, through postnatal stages, as expected
Exp Paradigm: Immunohistochemistry
 Immunohistochemistry
 P1, p7
Gene expression1
Abnormal
Description: Downregulation of several genes was observed, notably reln, in the granule cell precursors isolated from chd7 gcp specific knockout mice
Exp Paradigm: NA
 Rna sequencing
 P7
Ultrasonic vocalization1
 No change
 Monitoring ultrasonic vocalizations
 P42-45
Size/growth1
 No change
 Body weight measurement
 P2- 4 months
Anxiety1
 No change
 Open field test
 P42-45
Olfactory learning and memory1
 No change
 Olfactory habituation-dishabituation test
 P42-45
Spatial learning1
 No change
 Morris water maze test
 P42-45
Grip strength1
 No change
 Grip strength test
 P42-45
Motor coordination and balance1
 No change
 Accelerating rotarod test
 P42-45
Repetitive digging1
 No change
 Marble-burying test
 P42-45
Social approach1
 No change
 Three-chamber social approach test
 P42-45
Social interaction1
 No change
 Reciprocal social interaction test
 P21, adult
 Not Reported: Circadian sleep/wake cycle, Immune response, Maternal behavior, Physiological parameters, Seizure, Sensory

M_CHD7_4_CKO_HM_ATOH1

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Cerebellar foliation1
abnormal
Description: Cerebellar microgyria, eight folds were detected along the mediolateral axis of the anterior cerebellar vermis with 100% penetrance; anteriorâ??posterior foliation of the cerebellar vermis was significantly reduced; mediolateral length of the cerebellum was significantly increased; anteriorâ??posterior and dorsoventral lengths were significantly decreased
 Histology
 P56
Protein-dna complex assembly1
decreased
Description: Chd7-occupied 22,515 genomic sites in analysis of anterior cerebellum of wt mice and chd7 chip signal was reduced in conditional chd7 knockout mice
 Chromatin immunoprecipitation sequencing (ChIP-seq)
 P4
Cerebellar morphology: granule cell layer thickness1
abnormal
Description: Internal granule layer displayed altered thickness
 Histology
 P56
Cell proliferation: neural precursors: granule cell precursors1
abnormal
Description: Higher ratio of vertical to horizontal divisions in the anteriorâ??posterior plane compared to the mediolateral plane in control mice; ratio of vertical to horizontal divisions was reduced in the anteriorâ??posterior plane and increased in the mediolateral plane
 Immunohistochemistry
 P3
Neuronal morphology1
abnormal
Description: Bergmann glial fibers and purkinje cell bodies displayed a disorganized, irregular arrangement within their respective layers
 Histology
 P56
Cerebellar morphology1
abnormal
Description: Onset of aberrant folding, marked by the emergence of a single sulcus at the mediolateral midpoint of the anterior cerebellar vermis; by p3.5, two symmetric microgyri had developed around the initial midline sulcus; by p4, four distinct microgyri had emerged
Exp Paradigm: nano CT
 Cranial computerized tomography (CT) scan
 P3
Chromatin modification: histone modification: open chromatin1
decreased
Description: H3k27ac chip-seq signal at chd7-bound sites was significantly reduced
 Chromatin immunoprecipitation sequencing (ChIP-seq)
 P4
Cerebellar foliation1
abnormal
Description: Pattern of cerebellar microgyria in adult conditional chd7 knockout mice appeared by p7
Exp Paradigm: nano CT
 Cranial computerized tomography (CT) scan
 P7
Protein-dna complex assembly1
decreased
Description: Reduced the binding of rnapii at chd7-bound active enhancers in granule cell precursors
 Chromatin immunoprecipitation sequencing (ChIP-seq)
 P4
Chromatin modification: histone modification: open chromatin1
decreased
Description: Concordant reduction in accessibility and the expression of topologically associated genes
Exp Paradigm: log2 fold-change of RNA signal for genes proximal to CHD7-bound sites with significant changes in accessibility in the CHD7 cKO
 RNA-sequencing
 P4
Eye blink conditioning1
decreased
Description: Impaired cerebellar-dependent eye-blink conditioning
 Eyeblink conditioning
 8w
Chromatin modification1
abnormal
Description: Correlation of genomic interaction frequency with enhancer accessibility and h3k27ac levels
Exp Paradigm: in situ chromosome conformation capture with high-throughput sequencing (Hi-C)
 High-throughput Sequencing (Hi-C)
 P4
Targeted expression1
decreased
Description: Analyses of micro-dissected anterior cerebellar vermis showed effective depletion of chd7 in conditional chd7 knockout mice
 Western blot
 P4
Differential gene expression1
increased
Description: 2144 genes were significantly upregulated upon conditional chd7 knockout
 RNA-sequencing
 P4
Transcriptionally active chromatin1
decreased
Description: Depletion of chd7 significantly reduced chromatin accessibility at chd7-bound sites relative to non-bound regulatory elements; 83% of chd7-bound active enhancers exhibited decreased chromatin accessibility upon chd7 depletion
 Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-Seq)
 P4
Differential gene expression1
decreased
Description: 2095 genes were significantly downregulated upon conditional chd7 knockout
 RNA-sequencing
 P4
Targeted expression1
decreased
Description: Chd7 depletion in granule cell precursors in the anterior and central cerebellar vermis upon conditional knockout of chd7 using the math1-cre line
 Immunohistochemistry
 P4
Chromatin modification1
 no change
 High-throughput Sequencing (Hi-C)
 P4
Motor coordination and balance1
 no change
 Footprint analysis
 5w
Cell proliferation: neural precursors: granule cell precursors1
 no change
 Immunohistochemistry
 P4
Chromatin modification: histone modification: open chromatin1
 no change
 Chromatin immunoprecipitation sequencing (ChIP-seq)
 P4
General locomotor activity: ambulatory activity1
 no change
 Open field test
 5w
Neuronal migration1
 no change
 Immunofluorescence staining
 P4
Neuronal number1
 no change
 Immunohistochemistry
 P3
Protein-dna complex assembly1
 no change
 High-throughput Sequencing (Hi-C)
 P4
Protein-dna complex assembly1
 no change
 Chromatin immunoprecipitation sequencing (ChIP-seq)
 P4
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
ARID2 AT rich interactive domain 2 (ARID, RFX-like) 196528 Q68CP9 IP/WB
Bajpai R , et al. 2010
BAF155 SWI/SNF complex subunit SMARCC1 6599 Q92922 MS/MS; IP/WB
Laurette P , et al. 2015
BAF170 SWI/SNF complex subunit SMARCC2 6601 Q8TAQ2 MS/MS; IP/WB
Laurette P , et al. 2015
BRD7 bromodomain containing 7 29117 Q9NPI1 IP; MS; IP/WB
Bajpai R , et al. 2010
BRG1 Transcription activator BRG1 6597 P51532 MS/MS; IP/WB
Laurette P , et al. 2015
CHD8 chromodomain helicase DNA binding protein 8 57680 Q9HCK8 Y2H; Bimolecular fluorescence complementation assay; IP/WB
Batsukh T , et al. 2010
CTCF CCCTC-binding factor (zinc finger protein) 10664 B5MC38 GST
Allen MD , et al. 2007
FAM124B Protein FAM124B 79843 Q9H5Z6 Y2H; IP/WB; MS
Batsukh T , et al. 2013
FMR1 fragile X mental retardation 1 2332 G8JLE9 PAR-CLIP; RNA immunoprecipitation (RIP)
Ascano M Jr , et al. 2012
MITF microphthalmia-associated transcription factor 4286 O75030 MS/MS; IP/WB
Laurette P , et al. 2015
NLK nemo-like kinase 51701 Q9UBE8 GST
Takada I , et al. 2007
PARP1 poly (ADP-ribose) polymerase 1 142 P09874 IP; MS
Bajpai R , et al. 2010
PBRM1 polybromo 1 55193 Q86U86 IP; MS; IP/WB
Bajpai R , et al. 2010
PPARG peroxisome proliferator-activated receptor gamma 5468 P37231 GST
Takada I , et al. 2007
SETDB1 SET domain, bifurcated 1 9869 Q15047 GST
Takada I , et al. 2007
SMARCA4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 6597 A7E2E1 IP; MS; IP/WB
Bajpai R , et al. 2010
SMARCB1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 6598 Q12824 IP; MS
Bajpai R , et al. 2010
SMARCC1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 6599 Q58EY4 IP; MS; IP/WB
Bajpai R , et al. 2010
SMARCC2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 6601 Q8TAQ2 IP; MS; IP/WB
Bajpai R , et al. 2010
SMARCD1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 6602 Q96GM5 IP; MS
Bajpai R , et al. 2010
SMARCD2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 6603 Q92925 IP; MS
Bajpai R , et al. 2010
SMARCD3 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 6604 Q6P9Z1 IP; MS
Bajpai R , et al. 2010
SMARCE1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 6605 Q969G3 IP; MS; IP/WB
Bajpai R , et al. 2010
SOX9 SRY (sex determining region Y)-box 9 6662 P48436 ChIP-qPCR
Bajpai R , et al. 2010
TERF2 telomeric repeat binding factor 2 7014 Q9NYB0 Affinity chromatography; MS
Giannone RJ , et al. 2010
TOP3B topoisomerase (DNA) III beta 8940 O95985 HITS-CLIP
Xu D , et al. 2013
TWIST1 twist homolog 1 (Drosophila) 7291 Q15672 ChIP-qPCR
Bajpai R , et al. 2010
ZBTB20 zinc finger and BTB domain containing 20 26137 Q9HC78 ChIP; MS
IP; MS
Engelen E , et al. 2011
ABAT 4-aminobutyrate aminotransferase 268860 P61922 ChIP-Seq
Engelen E , et al. 2011
ABI2 abl-interactor 2 329165 P62484 ChIP-Seq
Engelen E , et al. 2011
ARID1A AT rich interactive domain 1A (SWI-like) 93760 A2BH40 IP; MS
Engelen E , et al. 2011
BCAR3 breast cancer anti-estrogen resistance 3 29815 Q9QZK2 ChIP-Seq
Engelen E , et al. 2011
CCNC cyclin C 51813 Q62447 ChIP-Seq
Engelen E , et al. 2011
CDK8 cyclin-dependent kinase 8 264064 Q8R3L8 ChIP-Seq
Engelen E , et al. 2011
CMTM3 CKLF-like MARVEL transmembrane domain containing 3 68119 Q99LJ5 ChIP-Seq
Engelen E , et al. 2011
CORO1C coronin, actin binding protein 1C 23790 Q9WUM4 ChIP-Seq
Engelen E , et al. 2011
CPD carboxypeptidase D 12874 O89001 ChIP-Seq
Engelen E , et al. 2011
CSRP1 cysteine and glycine-rich protein 1 1465 P97315 ChIP-Seq
Engelen E , et al. 2011
DYNC1LI2 dynein, cytoplasmic 1 light intermediate chain 2 234663 Q6PDL0 ChIP-Seq
Engelen E , et al. 2011
E2F1 E2F transcription factor 1 13555 Q61501 ChIP
Schnetz MP , et al. 2010
EEF1E1 eukaryotic translation elongation factor 1 epsilon 1 66143 Q9D1M4 ChIP-Seq
Engelen E , et al. 2011
EGFR epidermal growth factor receptor 13649 Q01279 ChIP-Seq
Engelen E , et al. 2011
EIF1AY eukaryotic translation initiation factor 1A, X-linked 66235 Q8BMJ3 ChIP-Seq
Engelen E , et al. 2011
EP300 E1A binding protein p300 328572 B2RWS6 ChIP; IP/WB
Schnetz MP , et al. 2010
EZH2 enhancer of zeste homolog 2 (Drosophila) 14056 Q61188 ChIP
Schnetz MP , et al. 2010
FAM190B granule cell antiserum positive 14 72972 Q3UHI0 ChIP-Seq
Engelen E , et al. 2011
FGD4 FYVE, RhoGEF and PH domain containing 4 224014 Q91ZT5 ChIP-Seq
Engelen E , et al. 2011
FRMD4B FERM domain containing 4B 232288 Q920B0 ChIP-Seq
Engelen E , et al. 2011
GATAD2A GATA zinc finger domain containing 2A 234366 Q8CHY6 IP; MS
Engelen E , et al. 2011
Gbx2 Homeobox protein GBX-2 14472 P48031 ChIP-qPCR
Yu T , et al. 2013
GLI2 GLI-Kruppel family member GLI2 14633 Q0VGT2 ChIP-Seq
Engelen E , et al. 2011
GLI3 GLI-Kruppel family member GLI3 14634 Q61602 ChIP-Seq
Engelen E , et al. 2011
GRIA2 glutamate receptor, ionotropic, AMPA2 (alpha 2) 14800 P23819 ChIP-Seq
Engelen E , et al. 2011
HES5 hairy and enhancer of split 5 (Drosophila) 15208 P70120 ChIP-Seq
Engelen E , et al. 2011
ITGA6 integrin alpha 6 16403 Q61739 ChIP-Seq
Engelen E , et al. 2011
JAG1 jagged 1 16449 Q9QXX0 ChIP-Seq
Engelen E , et al. 2011
KCTD17 potassium channel tetramerisation domain containing 17 72844 E0CYQ0 ChIP-Seq
Engelen E , et al. 2011
KLF15 Kruppel-like factor 15 66277 Q9EPW2 ChIP-Seq
Engelen E , et al. 2011
LSM6 LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) 78651 P62313 ChIP-Seq
Engelen E , et al. 2011
MAPT microtubule-associated protein tau 17762 P10637 ChIP-Seq
Engelen E , et al. 2011
MOB3B MOB kinase activator 3B 214944 Q8VE04 ChIP-Seq
Engelen E , et al. 2011
MTA1 metastasis associated 1 116870 Q8K4B0 IP; MS
Engelen E , et al. 2011
MTA2 metastasis-associated gene family, member 2 23942 Q9R190 IP; MS
Engelen E , et al. 2011
MYC myelocytomatosis oncogene 17869 P01108 ChIP
Schnetz MP , et al. 2010
MYCN v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) 18109 P03966 ChIP
Schnetz MP , et al. 2010
NANOG Nanog homeobox 71950 Q80Z64 ChIP
Schnetz MP , et al. 2010
NRAS neuroblastoma ras oncogene 18176 P08556 ChIP-Seq
Engelen E , et al. 2011
OLIG1 oligodendrocyte transcription factor 1 116448 Q9JKN5 IP; MS
Engelen E , et al. 2011
Otx2 Homeobox protein OTX2 P80206 ChIP-qPCR
Yu T , et al. 2013
OXCT1 3-oxoacid CoA transferase 1 67041 Q9D0K2 ChIP-Seq
Engelen E , et al. 2011
p53 Cellular tumor antigen p53 22059 P02340 ChIP; qRT-PCR
Van Nostrand JL , et al. 2014
PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 170768 A7UAK4 ChIP-Seq
Engelen E , et al. 2011
POU5F1 POU domain, class 5, transcription factor 1 18999 P20263 ChIP; ChIP-Seq; ChIP-chip
Schnetz MP , et al. 2010
RAB33B RAB33B, member of RAS oncogene family 19338 O35963 ChIP-Seq
Engelen E , et al. 2011
RBPJ recombination signal binding protein for immunoglobulin kappa J region 19664 P31266 ChIP-Seq
Engelen E , et al. 2011
RGS8 regulator of G-protein signaling 8 67792 Q8BXT1 ChIP-Seq
Engelen E , et al. 2011
RNF2 ring finger protein 2 19821 Q9CQJ4 ChIP
Schnetz MP , et al. 2010
SALL3 sal-like 3 (Drosophila) 20689 Q62255 IP; MS
Engelen E , et al. 2011
SEC63 SEC63-like (S. cerevisiae) 140740 Q8VHE0 ChIP-Seq
Engelen E , et al. 2011
SLC25A36 solute carrier family 25, member 36 192287 Q922G0 ChIP-Seq
Engelen E , et al. 2011
SMAD1 MAD homolog 1 (Drosophila) 17125 P70340 ChIP
Schnetz MP , et al. 2010
SMAD5 SMAD family member 5 17129 P97454 Y2H; GST
Liu Y , et al. 2013
SMAD8 Mothers against decapentaplegic homolog 9 55994 Q9JIW5 Y2H; GST
Liu Y , et al. 2013
Sox10 SRY-box containing gene 10 20665 Q04888 IP/WB; Co-localization
ChIP-Seq
He D , et al. 2016
SOX11 SRY-box containing gene 11 20666 Q7M6Y2 ChIP-Seq
Engelen E , et al. 2011
SOX2 SRY-box containing gene 2 20674 P48432 Affinity chromatography; MS; IP/WB; GST; IP
Engelen E , et al. 2011
Sox3 P53784 ChIP-Seq; ChIP-chip
Sharov AA , et al. 2014
SPEG SPEG complex locus 11790 Q62407 ChIP-Seq
Engelen E , et al. 2011
SRC Rous sarcoma oncogene 20779 P05480 ChIP-Seq
Engelen E , et al. 2011
STAT3 signal transducer and activator of transcription 3 20848 P42227 ChIP
Schnetz MP , et al. 2010
SUZ12 suppressor of zeste 12 homolog (Drosophila) 52615 Q80U70 ChIP
Schnetz MP , et al. 2010
SYNE2 synaptic nuclear envelope 2 319565 Q6ZWQ0 ChIP-Seq
Engelen E , et al. 2011
TADA1 transcriptional adaptor 1 27878 Q99LM9 ChIP-Seq
Engelen E , et al. 2011
Tcf3 transcription factor 3 21423 P15806 ChIP-Seq; ChIP-chip
Sharov AA , et al. 2014
TGFBR2 transforming growth factor, beta receptor II 21813 Q62312 ChIP-Seq
Engelen E , et al. 2011
TMEM132C transmembrane protein 132C 208213 Q8CEF9 ChIP-Seq
Engelen E , et al. 2011
TPM1 tropomyosin 1, alpha 22003 P58771 ChIP-Seq
Engelen E , et al. 2011
TULP3 tubby-like protein 3 22158 O88413 ChIP-Seq
Engelen E , et al. 2011
VARS valyl-tRNA synthetase 22321 Q9Z1Q9 IP; MS
Engelen E , et al. 2011
ZBTB20 zinc finger and BTB domain containing 20 56490 Q8K0L9 ChIP; MS
IP; MS
Engelen E , et al. 2011
ZFX zinc finger protein X-linked 22764 P17012 ChIP
Schnetz MP , et al. 2010
ZHX3 zinc fingers and homeoboxes 3 320799 Q8C0Q2 ChIP-Seq
Engelen E , et al. 2011
Creb3l2 cAMP responsive element binding protein 3-like 2 362339 Q6QDP7 ChIP-Seq; qRT-PCR
He D , et al. 2016
Mbp myelin basic protein 24547 P02688 ChIP-Seq; qRT-PCR
He D , et al. 2016
Myrf myelin regulatory factor 293736 D4A352 ChIP-Seq; qRT-PCR
He D , et al. 2016
Olig2 oligodendrocyte lineage transcription factor 2 304103 G3V612 ChIP-Seq
He D , et al. 2016
Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 171379 Q8K1P7 ChIP-Seq; Expression microarray
He D , et al. 2016
Sox10 SRY box 10 29361 O55170 IP/WB; Co-localization
ChIP-Seq
He D , et al. 2016
Sp7 Sp7 transcription factor 300260 Q6IMK2 ChIP-Seq; qRT-PCR
He D , et al. 2016
Ugt8 UDP glycosyltransferase 8 50555 Q09426 ChIP-Seq
He D , et al. 2016

HELP
Copyright © 2017 MindSpec, Inc.